Salon: “Perdue bought [stock] the day Pfizer warned investors the pandemic might hurt the company. The next day, he bought more”
ATLANTA — In keeping with Perdue’s previously exposed “well-timed” stock trades, a new Salon report revealed that Senator David Perdue purchased Pfizer stock one week before the company publicly announced it would be developing a coronavirus vaccine, raising more questions about what Perdue knew and when.
Despite Pfizer warning investors in late February of potentially negative impacts the virus could have on its operations, Perdue’s broker chose to buy more Pfizer stock that day, and even more the next day, when Perdue’s office issued its first press release about COVID-19, noting that the U.S. was “expediting the development of a vaccine.” A week later, Pfizer announced a partnership with a company to develop a vaccine that it theorized could be brought to market faster than traditional vaccines. This latest stock trading scandal adds to a robust list of self-dealing controversies Senator Perdue has been embroiled in where legal experts have deemed the timing of Perdue’s acquisitions “suspicious” or akin to “batting 100 percent.”
“When the coronavirus was first beginning to spread across the country, Senator Perdue was focusing on getting richer instead of saving lives,” said Braxton Brewington, spokesman for the Democratic Party of Georgia. “Perdue should be ashamed, and Georgia voters won’t forget how he put his paycheck before the health and safety of millions of families.”
February 1, 2023
January 31, 2023
January 27, 2023